Across TCGA pan-cancer cohorts, MSANTD1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MSANTD1 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MSANTD1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MSANTD1 expression acts as an unfavorable survival marker.

UCEC and SKCM are the cancer types where MSANTD1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	DFS	Median	III,IV	0.058	0.597	.007	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MSANTD1 tumor-vs-normal RNA expression · all MSANTD1 data types